Who is this study for: Child to adult patients with Mucopolysaccharidosis Disorder, Glycoprotein Metabolic Disorder, Sphingolipidoses and Recessive Leukodystrophy, Peroxisomal Disorder, Osteopetrosis, Hereditary Leukoencephalopathy, or other Inherited Metabolic Disorders
Status: Recruiting
Start Date: July 10, 2014
Intervention Type: Drug, Biological
Study Drugs: Anti-thymocyte, Fludarabine, Alemtuzumab, Celecoxib, Rituximab
Phase: Phase 2